ERBB2 and breast cancer: In our research, the multiple linear regression analysis identified a significant positive correlation between Ki67 LI and Emax, but this was exclusive to the HR + HER2-BC subtype (β 0.43, 95% CI 0.026–0.837, Supplementary Table S3).